Cargando…
Retraction: Coagulation factor 2 thrombin receptor promotes malignancy in glioma under SOX2 regulation
Autores principales: | Gao, Guojun, Yang, Ming, Wang, Fan, Dang, Ge, Zhang, Xiaoling, Zhao, Jing, Wang, Xiangyang, Jin, Baozhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512497/ https://www.ncbi.nlm.nih.gov/pubmed/32507767 http://dx.doi.org/10.18632/aging.204295 |
Ejemplares similares
-
Coagulation factor 2 thrombin receptor promotes malignancy in glioma under SOX2 regulation
por: Gao, Guojun, et al.
Publicado: (2020) -
[Retracted] MicroRNA‑21 promotes migration and invasion of glioma cells via activation of Sox2 and β‑catenin signaling
por: Luo, Guoxuan, et al.
Publicado: (2023) -
Retraction: MicroRNA-371-5p targets SOX2 in gastric cancer
por: Li, Yu-Ji, et al.
Publicado: (2018) -
Retracted: Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retracted: Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Engineering, Journal of Healthcare
Publicado: (2023)